UBE2E1 and osteosarcoma: To ascertain whether the effect on UBE2E1 levels of an Otub1 deletion was specific to MEFs, we used CRISPR-Cas9 (36, 37) to knock out OTUB1 gene expression in human osteosarcoma (U2OS) cells.